Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
>=5-<10 >=5-<10
General Information
Version
2023/09/29
Revision date
2023-12-24
Product name
CNTO 4424 (Drug Product) RYBREVANT
Substance name
CNTO 4424 (Drug Product) RYBREVANT
1.2.1 Relevant identified uses
Large Molecule Pharmaceutical intended for medical use Bispecific/Multispecific antibody
supplier name
Janssen Pharmaceuticals, Inc
Emergency telephone
+16097302000, 1 -800 -424 -9300, +1 703 -741 -5970
Icons in SDS
Company Information
company name
Janssen Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJanssen@its.jnj.com
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Not a hazardous substance or mixture.
2.3 Other hazards
Avoid direct contact and significant aeroso l/dust exposure which has the remote possibilities of eliciting an allergic response. May cause sensitization in susceptible persons. This material is not likely to be significantly absorbed via occupational routes of entry due to its chemical structure an d large molecular weight. May damage the developing embryo/fetus if administered parenterally at therapeutic concentrations. Maternal systemic exposure from worker handling is expected to be negligible and embryo/fetal harm from worker exposure is consider ed unlikely.
2.1 Classification of the substance or mixture
1910.1200) Not a hazardous substance or mixture.
